O
RGEN icon

Ossiam’s Repligen RGEN Stock Holding History

Ossiam’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,583
Closed -$516K – 646
2024
Q4 		$516K Sell
3,583
-1,105
-24% -$158K 0.01% 449
2024
Q3 		$698K Buy
4,688
+2,740
+141% +$393K 0.01% 405
2024
Q2 		$246K Buy
1,948
+77
+4% +$12.1K ﹤0.01% 523
2024
Q1 		$344K Buy
1,871
+387
+26% +$73.7K 0.01% 535
2023
Q4 		$267K Hold
1,484
– – ﹤0.01% 568
2023
Q3 		$236K Buy
1,484
+60
+4% +$9.81K ﹤0.01% 590
2023
Q2 		$201K Buy
1,424
+680
+91% +$109K ﹤0.01% 616
2023
Q1 		$125K Buy
744
+209
+39% +$37.3K ﹤0.01% 563
2022
Q4 		$90.6K Hold
535
– – ﹤0.01% 593
2022
Q3 		$100K Buy
+535
New +$113K ﹤0.01% 567

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Ossiam's RGEN Position: Q1 2025 in Review

Ossiam sold out of Repligen (RGEN) in Q1 2025, closing a stake of 3,583 shares — an estimated $516K sold.

Ossiam first reported a position in RGEN in Q3 2022 and held it in 10 quarters. The position peaked at $698K in Q3 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Ossiam reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Ossiam sold 3,583 Repligen shares in Q1 2025, an estimated $516K.
  • Ossiam first reported a position in Repligen in Q3 2022 and held it in 10 quarters.
  • Ossiam's Repligen position peaked at $698K in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Ossiam's 13F filing for Q1 2025, filed 14 May 2025.